We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Severe COVID-19 is defined as SARS-CoV-2 infection with hypoxemia, respiratory distress (respiratory rate >30), and/or severe pneumonia on imaging (>50% infiltrates). 46, 47 Patients with ...

Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...

Drugmakers who seized the opportunity to develop vaccines against the coronavirus are on their way to reaping significant revenues. Exactly how much money is on the table? In its annual forecast for ...

Obesity is a clear risk factor for COVID-19 complications, so what can nurse practitioners and physician assistants do to keep their patients with obesity safe and healthy? From the onset of the COVID ...